the part everyone’s reacting to is the undisclosed pharmacy and the state licensing, which is legit and worth the documentation you’re already pulling. but the 1.5ml injection is the thing I’d actually isolate, because that’s not a pharmacy-identity problem, it’s a concentration problem, and the two get conflated constantly. quick frame on why the volume jumped, because this is the variable that bites people switching compounders mid-cycle: nominal dose (mg) and injection volume (ml) are not the same number. same “10mg” can be 0.25ml at one compounder and over a full ml at another, entirely depending on how concentrated they reconstitute the vial. branded zepbound is fixed mg per pen, no dilution to think about, so people carry over a mental “my dose is about this much liquid” and it falls apart the second the concentration changes under them. so the comparison that matters here isn’t BPI vs whoever filled it as two brand reputations. it’s: - what mg/ml was the vial you selected reconstituted to
- what mg/ml is the one that actually showed up if the substitute is running a more dilute prep, your mg can be identical and your injection volume balloons to 1.5ml. that’s almost certainly what happened. a 1.5ml subq is real and uncomfortable but it’s not a 1.5ml-worth-of-drug overdose, assuming the mg is what you ordered. worth confirming the mg/ml on the label before you assume the dose itself is wrong, because the panic and the actual risk are two different things here. the other thing, and this is the one I’d push on for next time: the platforms not letting you confirm post-prescription is the structural failure, agreed. but the lever you have is asking for the lot-specific concentration and potency testing up front, not just the pharmacy name. a serious operation publishes that. the name on the vial tells you less than the mg/ml does. fwiw your instinct to document is right. just point it at the concentration spec, not only the licensing.